FASLG and systemic lupus erythematosus: Even though aPL and APS remain an important cause of CVD including thrombosis in SLE, recent studies indicate that improved treatment, with hydroxychloroquine, life‐long anticoagulant treatment, statins, and optimization of prednisolone treatment, has considerably improved prognosis and thus other causes of CVD in SLE become relatively more important [78].